An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.

Alessandra Mosca, Ugo De Giorgi, Camillo Porta, Giuseppe Procopio, Umberto Basso, Giacomo Cartenì, Matteo Bersanelli, Emanuele Naglieri, L. Galli, Orazio Caffo, Giuseppe Fornarini, F Boccardo, C. Porta

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study.'. Together they form a unique fingerprint.

Medicine & Life Sciences